curriculum vitaejommid.pasteur.ac.ir/files/site1/pages/amitis_ramezani.pdf1 curriculum vitae name:...

1

Curriculum Vitae

Name: Amitis Ramezani

Address: Clinical Research Department, Pasteur Institute of Iran, No. 69, Pasteur Ave.,

Tehran 1316943551, Iran

Tel: (+98-21) 6696 8852

Fax: (+98-21) 66465147

E-mail: [email protected]

Education

• Infectious Disease Specialist. Tehran University of Medical Sciences

• MPH. Faculty of Health, Tehran University of Medical Sciences

Associations/Membership

• Editorial Board of Iranian Journal of Infectious Diseases and Tropical

Medicine

• Editorial Board of Gastroenterology and Hepatology research

• Regional Editor of Asian Journal of Medical Sciences

• Editorial Board of Hepatitis Monthly

• Member of the Board of Iranian Society for Support of Patients with

Infectious Diseases and Tropical Medicine

• Member of the Board of Infectious Diseases Society

• Member of the Board of Pediatric Infectious Disease Research Center of

Tehran University of Medical Sciences

2

• Permanent Member of Infectious Disease and Tropical Medicine Research

Center of Shaheed Beheshti Medical Sciences University

• Member of International AIDS Society (IAS)

• Member of International Society for Infectious Diseases (ISID)

• Member of European Society of Clinical Microbiology and Infectious Diseases

(ESCMID)

• Member of Nosocomial Infection, Vaccination, HIV, Hepatitis, Tuberculosis,

IT Committee of Infectious Research Center of Shaheed Beheshti University

• Member of Scientific Executive Committee of Iranian Infectious Diseases

Conferences (9th-21st)

• Member of Scientific Executive Committee of The first annual AIDS research

congress of Iran. 2007

• Scientific Executive Committee of National Iranian Congress of Brucellosis 5-

6 July 2005

• Scientific Executive Committee of Hepatitis B Seminar Held in Shaheed

Beheshti University

• Scientific Executive Committee of Immunology Seminar held in Sari 2004

• Member of Scientific Committee of 11th annual congress of pathology and 5th

annual congress of Iranian cancer association

• Member of Scientific Committee of the 3rd

and 4th Annual Iranian Congress

on HIV/AIDS.

• Member of Scientific Committee of National Congress on Brucellosis(2011)

• Member of Scientific Committee of 1st international and 5th National

HIV/AIDS Congress (2012)

3

Journal referee for:

• International journal of infectious disease

• Iranian journal of infectious disease and tropical medicine

• Iranian journal of Clinical infectious diseases

• Iranian journal of pathology

• International journal of clinical practice

• Hepatitis monthly journal

• Iranian journal of clinical infectious diseases

• International Journal of STD & AIDS

• Indian Journal of Medical Sciences

• Journal of Clinical Virology

• Annals of Clinical Microbiology and Antimicrobials

• African Journal of Microbiology Research

Projects:

• Comparing efficacy of two strategies of HBV vaccination in HIV infected

patients (2012-2015)

• Frequency of human papillomavirus infection in colon tissues of patients with

colon adenocarcinoma and adenomatous polyps referring to Shaheed Beheshti

University hospitals (2012)

• Frequency of occult Hepatitis B infection and S gene mutations in dialysis

patients (2012)

• Seroepidemiology of IgG antibodies against Diphtheria and Tetanus in blood

donors of Arak city(2012)

4

• Comparing efficacy of two strategies of HBV vaccination in HIV infected

patients (2011)

• Serum profile of T helper 1 and 2 cytokines in patients with chronic hepatitis

C virus infection(2011)

• Association of interleukin-10 gene promoter polymorphisms with outcome of

hepatitis B virus infection (2011)

• TH1/TH2 cytokine levels as an indicator for disease progression in human

immunodeficiency virus type 1 infected patients(2011)

• Prevalence and genotype determination of HTLV 1 & 2 in HIV positive

patients (2010-2011)

• Frequency and genotype of hepatitis D virus in high risk groups for hepatitis B

virus acquisition (2010)

• Seroepidemiology of IgG antibody against Bordetella pertussis in 6-20 years

age group habitant of Tehran (2009-2010)

• Occult hepatitis B virus infection and mutations in the S gene region in

vaccinated children (2009-2010)

• Association of polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with

outcome of hepatitis B virus infection (2008-2010)

• Frequency of human papillomavirus infection in patients with breast

carcinoma and benign breast samples referring to Shohada , Loghman and

Imam Khomeini hospitals (2009-2010)

• Seroepidemiology of IgG antibody against Bordetella pertussis in 6-20 years

age group habitant of Tehran (2009-2010)

• Seroepidemiology of antibody against Hepatitis A virus (anti-HAV) in 8

months to 20 years age group habitant of Tehran (2009)

5

• Frequency of occult Hepatitis B virus infection in blood donors with isolated

anti-HBc in Arak city (2009)

• Assessment of antibody levels to Hepatitis B virus surface antigen in routinely

vaccinated children via vaccination program of Iran (2009)

• Frequency of human papillomavirus infection in prostate tissues of patients

with prostate carcinoma and benign prostatic hyperplasia referring to Shaheed

Beheshti University hospitals (2008-2010)

• Prevalence and genotype of hepatitis G virus in Human Immunodeficiency

Virus (HIV) infected patients(2007-2008)

• Hepatitis B virus genotyping in hepatocellular carcinoma in Iranian patients

(2006-2008)

• Frequency of HLA Ι,ΙΙ(A,B,DRB) in chronic Hepatitis B virus patients(2006-

2007)

• Predictive value and cut off point of PPD in pulmonary tuberculosis patients in

Arak(2007-2009)

• Trial due to recombinant hepatitis B (HB) vaccine in hemodialysis patients of

3 dialysis center of Imam Khomeini, Sina , Amiralam Hospitals (2005-2007)

• Frequency of of Hepatitis G (HGV) in Blood Donors in Tabriz (2005-2006)

• Frequency of of Hepatitis G (HGV) in Hemodialysis and peritoneal dialysis

patients and dialysis ward staff in Imam Khomeini (2005-2006)

• Survey relation age of vaccinated infant (0, 2,6 months) and blood

concentration of mercury (2005-2006)

• Frequency of YMDD mutation in chronic Hepatitis B patients (2005-2006)

• Frequency of proteinuria in HIV positive patient in behavior diseases

consultant of Shaheed Beheshti Medical Sciences (2004-2005)

6

• Study relation of Antiretroviral drugs (include protease inhibitor) with

Lipodistrophy in HIV positive patients in behavior diseases consultant of

Shaheed Beheshti Medical Sciences (2004 -2005)

• Identification and detection of drug resistancy and genotyping of clinical

strains of enterococci isolated from admitted patients in Tehran University

Hospitals (2002 -2005)

Papers:

• Ehteram H, Ramezani A, Eslamifar A, Sofian M, Banifazl M, Ghassemi SH,

Aghakhani A, Mashayekhi P. Seroprevalence of Hepatitis E Virus infection

among Volunteer Blood Donors in Central Province of Iran in 2012. Iranian

Journal of Microbiology (in press)

• Ramezani A, Banifazl M, Eslamifar A , Ahmadi F, Razeghi E and Aghakhani

A. Outcome of Hemodialysis Patients with Occult Hepatitis B Virus Infection

At 4 Year Follow-up. Journal of Gastrointestinal and Liver Diseases (in press)

• Sofian M, Sheikholeslami M, Mahdaviani F, Aghakhani A, Banifaz M,

Eslamifar A, Sarmadian H, Deiri G, Ramezani A. Low Prevalence of Brucella

agglutinins in Blood Donors in Central Province of Iran. Iranian Journal of

Microbiology 5(1):24-27(2013)

• Ramezani A, Banifazl M, Aghakhani A. GB Virus C Overview: Insights into

Clinical Implication. Journal of Gastroenterology and Hepatology Research.

2(1): 343-349 (2013)

• Eslamifar A, Aghakhani A, Mohraz M, Banifazl M, Foroughi M, Ansari F,

Bolandghamat Z, Ramezani A. Seroepidemiology of Hepatitis E Virus

7

Infection in HIV Infected Patients. Iranian Journal of Infectious Diseases and

Tropical Medicine 17(59):33-36(2013)

• Sofian M, Aghakhani A, FaraziA, Banifazl M, Eslamifar A, Rashidi N,

Khadem-Sadegh A and Ramezani A. Serum Profile of T helper 1 and T

helper 2 Cytokines in Hepatitis C virus Infected Patients. Hepatitis Monthly

12(12):e6156 (2012)

• Sofian M, Aghakhani A, Banifazl M, Azadmanesh K, Farazi A, McFarland W,

Eslamifar A and Ramezani A. Viral hepatitis and HIV infection among

injection drug users in a central Iranian city. Journal of Addiction Medicine

6(4):292-6 (2012)

• Aghakhani A, Banifazl M, Eslamifar A, Ahmadi F and Ramezani A. Viral

Hepatitis and HIV Infection in Hemodialysis Patients. Hepatitis Monthly

12(7): 463-464(2012)

• Ramezani A, Banifazl M, Eslamifar A, Sofian M and Aghakhani A. Occult

hepatitis B infection in different high risk patients. Hepatitis Monthly 12(7):

467-468(2012)

• Aghakhani A, Banifazl M, Velayati AA, Eslamifar A and Ramezani A.

Occult Hepatitis B Virus Infection in Hemodialysis Patients: A Concept for

Consideration. Therapeutic Apheresis and Dialysis 16(4):328-33(2012)

• Ramezani A, Banifazl M, Mamishi S, Sofian M, Eslamifar A and Aghakhani

A. The Influence of Human Leukocyte Antigen and IL-10 Gene

Polymorphisms in Hepatitis B Virus Outcome. Hepatitis Monthly 12(5):320-

325(2012)

8

• Eslamifar A, Ramezani A, Banifazl M, Khadem-Sadegh A and Aghakhani A.

Seroprevalence of IgG Antibodies against Bordetella Pertussis in Different

Age Groups in Tehran. Iranian Journal of Pathology 7(3):171-176(2012)

• Soufian S , Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Boland-

Ghamat Z, Khadem-Sadegh A and Ramezani A. No evidence of the Th1 to

Th2 cytokine shift during the course of HIV infection. Iranian Journal of

Pathology 7(2):88-93(2012)

• Ramezani A, Aghakhani A, Banifazl M, …….., Khadem-Sadegh A and

Mohraz M. Frequency of Human T-Cell Lymphotropic Virus (HTLV) Type 1

and 2 Infection in HIV Infected Patients. Iranian Journal of Pathology 7(1):9-

13(2012)

• Eslamifar A,

Ramezani A, Banifazl M and Aghakhani A. Tetanus and

diphtheria seroprevalence in patients infected with human immunodeficiency

virus. Iranian Journal of Pathology 7(1):27-31(2012)

• Soufian S, Mohraz M, Aghakhani A, Banifazl M, Froughi M, Eslamifar A,

Boland-Ghamat Z, Khadem-Sadegh A and Ramezani A. TH1/TH2 Cytokine

Levels in Human Immunodeficiency Virus Type 1 Infected Patient. Iranian

Journal of Infectious Diseases and Tropical Medicine 16(55):19-22(2012)

• Aghakhani A, Banifazl M, Izadi N, McFarland W, Sofian M, Khadem-Sadegh

A,….Eslamifar A, Ramezani A. Persistence of antibody to hepatitis B surface

antigen among vaccinated children in a low HBV endemic area. World Journal

of Pediatrics 7(4):358-60 (2011)

• Aghakhani A, Hamkar R, Parvin M, …., Banifazl M, Eslamifar A, Izadi N,

Jam S and Ramezani A. The Role of Human Papillomavirus Infection in

9

Prostate Carcinoma. Scandinavian Journal of Infectious Diseases 43(1): 64-

69(2011)

• Ramezani A, Banifazl M, Mohraz M, Eslamifar A, Rasoolinejad M and

Aghakhani A. Occult Hepatitis B Virus Infection: A Major Concern in HIV-

Infected Patients. Hepatitis Monthly 11(1):7-10 (2011)

• Ramezani A, Banifazl M, Eslamifar A and Aghakhani A. Association

between Human Papillomavirus Infection and Risk of Prostate Cancer

(Review article). Iranian Journal of Pathology 6 (1): 3-7(2011)

• Ramezani A, Banifazl M and Aghakhani A. Occult Hepatitis B Infection in

Chronic Hemodialysis Patients: Comparison of Results and Concepts.

Hepatitis Monthly 11(2):128-129 (2011)

• Kalantar E, Ramezani A, Hosseini S, Aghakhani A, Zarin Far N, Banifazl M

,………Eslamifar A and Sofian M. Interleukin-10 gene promoter

polymorphisms and hepatitis B virus infection outcome. Iranian Journal of

Infectious Diseases and Tropical Medicine 16(54):7-12(2011)

• Aghasadeghi MR, Mohraz M, Bahramali G, Aghakhani A, Banifazl M……

Eslamifar A and Ramezani A. Frequency of hepatitis D virus infection in HIV

positive and hemodialysis patients. Iranian Journal of Infectious Diseases and


• Hamkar R, Mohraz M, Lorestani S, Aghakhani A, Truong HM, McFarland W,

Banifazl M, Eslamifar A, ……. and Ramezani A. Assessing Subtype and

Drug-Resistance Associated Mutations among Antiretroviral-Treated HIV

Infected Patients. AIDS 24 (suppl 2):S85–S91 (2010)

• Aghakhani A, Banifazl M, Kalantar E, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Occult Hepatitis B Virus Infection in Hemodialysis Patients

10

with Isolated Hepatitis B Core Antibody: A Multicentre Study. Therapeutic

Apheresis and Dialysis 14(3):349–353 (2010)

• Ramezani A, Banifazl M, EslamifarA and Aghakhani A. Serological pattern

of anti-HBc alone infers occult hepatitis B virus infection in high-risk

individuals in Iran. Journal of Infection in Developing Countries 4(10):658-

661 (2010)

• Ramezani A, Hamkar R, Aghakhani A, Lorestani SH, Banifazl M, Truong

HH, McFarland W, Foroughi M, Eslamifar A and Mohraz M. Subtype

Mutations and Related Drug-Resistance in Anti-Retroviral Treated HIV

Infected Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine15(50):1-7(2010)

• Mohraz M, Ramezani A, Rasoulinejad M, Izadi M, Haji-abdolbaghi M,

Banifazl M and Aghakhani A. Comparison of the Efficacy and Safety of

Tenofovir-Emtricitabine Compound to other Antiretroviral Combinations.

Iranian Journal of Infectious Diseases and Tropical Medicine15(49):7-

10(2010)

• Eslamifar A, Aghakhani A, Banifazl M, Gachkar L, Khadem-Sadegh A,

Ramezani A. Seroprevalence of Bordetella Pertussis Antibodies in Different

Age Groups. Iranian Journal of Infectious Diseases and Tropical Medicine

15(49):43-47(2010)

• Sofian M, Aghakhani A, Farazi AA, Banifazl M, …, Eslamifar A, Khadem-

Sadegh A, Izadi N and Ramezani A. Seroepidemiology of Hepatitis A Virus

in Children of Different Age Groups in Tehran, Iran: Implications for Health

Policy. Travel Medicine and Infectious Disease 8(3): 176-179 (2010)

11

• Hamkar R, Parvin M, Ghavami N, Ramezani A, …, Banifazl M, ….,

Eslamifar A and Aghakhani A. Involvement of Human Papillomavirus

Infection in Prostate Carcinoma. Iranian Journal of Infectious Diseases and


• Sofian M. Moeeni L, ……. Aghakhani A Banifazl M, Ramezani A. Predictive

value and cut of point of PPD in probable patients with pulmonary

tuberculosis. Iranian Journal of Infectious Diseases and Tropical Medicine

15(48):19-21(2010)

• Ramezani A, Azadmanesh K, Aghakhani A, Banifazl M, …. and Sofian M.

Frequency of occult hepatitis B virus infection in injection drug users. Iranian

Journal of Infectious Diseases and Tropical Medicine 15(48):39-42(2010)

• Sofian M, Aghakhani A, Banifazl M, …Eslamifar A,…Ramezani A. Lack of

occult hepatitis B virus infection among blood donors with isolated anti-HBc

living in a HBV low prevalence region in Iran. International Journal of

Infectious Diseases 14(4):e308–e310 (2010)

• Hamkar R, Aghakhani A, Soufian S, Banifazl M, ….., Eslamifar A and

Ramezani A. Surface Gene Mutations of Hepatitis B Virus among High Risk

Patients with Occult HBV Infection. Diagnostic Microbiology and Infectious

Disease 66(3):285-291(2010)

• Izadi N, Aghakhani A, Banifazl M , … Eslamifar A , .., Khadem-Sadegh A

and Ramezani A. Persistence of Anti-HBs antibody in HB Vaccinated

Children in a Low Endemic Area for HBV. Iranian Journal of Infectious

Diseases and Tropical Medicine 14(47):39-42(2010)

• Ramezani A, Hamkar R, Soufian S, Banifazl M ,……, Eslamifar A and

Aghakhani A. Genetic variability of the S gene of hepatitis B virus among

12

High Risk Patients with Occult HBV Infection. Iranian Journal of Infectious


• Ramezani A, Sofian M, Banifazl M, …., Eslamifar A, Gachkar L, Khadem-

Sadegh A and Aghakhani A. Seroepidemiology of Hepatitis A Virus in

Children Residing in Tehran. Iranian Journal of Infectious Diseases and

Tropical Medicine 14(46):23-26 (2009)

• Velayati AA, Aghakhani A,....Eslamifar A....Ramezani A. Association of

polymorphism of HLA-DRB1*13 and HLA-A*33 alleles with outcome of

hepatitis B virus infection. Iranian Journal of Infectious Diseases and Tropical

Medicine 14(46): 11-14 (2009)

• Syed alinaghi A, Jam S,….Ramezani A, Mohraz M. The effect of

mindfulness-based stress reduction program (MBSR) upon CD4 count status

of HIV/AIDS infected patients. Iranian Journal of Infectious Diseases and


• Ramezani A, Banifazl M, Eslamifar A, Gachkar L, Aghakhani A. Prevalence

of hepatitis G virus in the sera of HIV infected patients with parenteral and

sexual exposure. Iranian Journal of Infectious Diseases and Tropical Medicine

14(45):27-29(2009)

• Ramezani A, Aghakhani A,…….. Eslamifar A, Sofian M. Occult hepatitis B

virus infection among blood donors in Arak. Iranian Journal of Infectious


• Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M. Frequency

of isolated anti-HBc in HIV- HCV co-infected patients. Iranian Journal of


13

• Aghakhani A, Hamkar R, Zamani N, Eslamifar A, Banifazl M, ….Ramezani

A. Hepatitis B Virus Genotype in Iranian Patients with Hepatocellular

Carcinoma . International Journal of Infectious Diseases13 (6):685-89(2009).

• Ramezani A, Banifazl M,……Eslamifar A…..and Aghakhani A. Occult

hepatitis B virus infection in hemodialysis patients. Iranian Journal of

Infectious Diseases and Tropical Medicine14(44):27-30(2009)

• Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A, ….

Frequency of Isolated Hepatitis B Core Antibody in HIV-HCV Coinfected

Individuals. International Journal of STD & AIDS 20(5):336-338(2009)

• Ramezani A, Aghakhani A, Kalantar E, Eslamifar A, Banifazl M …. HLA-

A*3303 and *3301 Predispose Patients to Persistent Hepatitis B Infection.

Journal of Gastrointestinal and Liver Diseases 18(1):117-8(2009)

• Jam S, Ramezani A, Sabzvari D, Moradmand-Badie B, Seyedalinaghi S,

Jabbari H, …. A cross-sectional study of anemia in human immunodeficiency

virus-infected patients in Iran. Arch Iran Med. 2009 Mar; 12(2):145-50.

• Ramezani A, …, Banifazl M, Eslamifar A and Aghakhani A. Significance of

Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection.

Iranian Journal of Pathology 4(2):80-84(2009)

• Ramezani A, Aghakhani A, Kalantar E, Banifazl M, Eslamifar A ,Velayati

AA. Association between Hepatitis B Virus Infection Outcome and HLA-A

and DRB1 Genotyping in North Part of Iran. Iranian Journal of Pathology

4(2):71-74(2009)

• Ramezani A,….,Aghakhani A,…..Prevalence of dyslipidemia and metabolic

abnormalities in HIV-infected patients. Acta Medica Iranica 47(2):83-

88(2009)

14

• Ramezani A,…..Aghakhani A, Taeb J,… Influence of HLA class Ι and II on

the outcome of hepatitis B virus infection Iranian Journal of Infectious

Diseases and Tropical Medicine13(43):1-4(2009)

• Ramezani A, ………Aghakhani A, Eslamifar A,…and Mohraz M. Frequency

of Occult Hepatitis B Virus Infection in HIV Infected Patients. Iranian Journal

of Infectious Diseases and Tropical Medicine13(43):17-20(2009)

• Kariminia A, sharifnia Z, Aghakhani A, Banifazl M, Eslamifar A, Hazrati M

and Ramezani A. Comparison of QuantiFERON TB-G test to TST for

detecting latent tuberculosis infection in a high-incidence area containing

BCG-vaccinated population. Journal of Evaluation in Clinical

Practice.15(1):148–151(2009)

• Ramezani A, Eslamifar A, ……and Aghakhani A. Efficacy and Long-term

Immunogenicity of Hepatitis B Vaccine in Hemodialysis Patients.

International Journal of Clinical Practice 63(3): 394-97(2009)

• Ramezani A, Hasanjani Roshan MR, Kalantar E, Eslamifar A,….Taeb J,

Aghakhani A… Association of Human Leukocyte Antigen polymorphism

with Outcomes to Hepatitis B Virus Infection. Journal of Gastroenterology

and Hepatology 23(11): 1716-1721 (2008).

• Aghakhani A, …, Banifazl M, …. Eslamifar A,…and Ramezani A.

Asymptomatic proteinuria in HIV-infected outpatients. Iranian Journal of


• Ramezani A, Eslamifar A,…… Aghakhani A ,…. High Blood Mercury

Levels in Iranian Infants: cause for concern. Iranian Journal of Pathology

3(4):186-190 (2008)

15

• Ramezani A, Mohraz M, Vahabpour R,….Eslamifar A,….Aghakhani

A,…Hekmat S. Frequency of Hepatitis G Virus Infection among HIV Positive

Subjects with Parenteral and Sexual Exposure. Journal of Gastrointestinal and

Liver Diseases 17(3):269-72 (2008)

• Azadmanesh K, …, Aghakhani A,……..Eslamifar A,….Ramezani A. Occult

Hepatitis B Virus Infection in HIV-Infected Patients with Isolated Hepatitis B

Core Antibody. Intervirology 51(4):270-274 (2008)

• Eslamifar A, Razzaghi-Abyaneh M,…… Ramezani A, Deljoodokht Z and

Aghakhani A. Frequency and Identification of Fungal Strains in Chronic

Rhinosinusitis Patients. Iranian Journal of Pathology 3(3):135-139(2008)

• Ramezani A, Aghakhani A ,… Eslamifar A,….Anemia prevalence and

related factors in a cohort of HIV- infected patients .Iranian Journal of

Pathology 3(3):125-128(2008)

• Hamkar R, Zamani N, Ramezani A, Eslamifar A, ......and Aghakhani A.

Identification of Hepatitis B Virus Genotype in Iranian Hepatocellular

Carcinoma Patients. Iranian Journal of Infectious Diseases and Tropical

Medicine13(41):23-29(2008)

• Ramezani A,…… Aghakhani A, Eslamifar A,….. Prevalence and Genotype

of Hepatitis G virus infection in HIV Positive Patients. Iranian Journal of

Infectious Diseases and Tropical Medicine13(41):7-13(2008)

• Hekmat S, …, Jam S, Bahramali G, Banifazl M, Aghakhani A, Eslamifar A,

…, Ramezani A. Frequency and Genotype of GB Virus C among Iranian

Patients Infected with HIV. Journal of Medical Virology 80(11):1941-

1946(2008)

16

• Ramezani A, …, Banifazl M, Eslamifar A,….and Aghakhani A. Frequency

and Associated Factors of Proteinuria in Iranian HIV-Positive Patients.

International Journal of Infectious Diseases 12(5):490-94(2008)

• Ramezani A, Aghakhani A, Eslamifar A….Taeb J,….. Long-Term Immunity

of Hepatitis B Vaccine in Patients Undergoing Hemodialysis. Iranian Journal

of Infectious Diseases and Tropical Medicine.13(40):21-24(2008)

• Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani A.

Evaluation of the blood gamma interferon assay for detection of latent

Tuberculosis infection: potential to replace the Mantoux skin test. Iranian

Journal of Infectious Diseases and Tropical Medicine13 (40):1-4(2008).

• Ramezani A, Velayati AA.,…….and Aghakhani A. Rate of YMDD Motif

Mutants in Lamivudine-Untreated Iranian Patients with Chronic Hepatitis B

Virus Infection. International Journal of Infectious Diseases. 12(3):252-

55(2008)

• Ramezani A, Eslamifar A,, ……and Aghakhani A. Persistence of Hepatitis B

Vaccine Immunity in Hemodialysis Patients.Therapeutic Apheresis and

Dialysis.12(2):143-146 (2008).

• Eslamifar A, Ramezani A, Razzaghi Abyaneh M, Fallahian V, Mashayekhi P,

…, Fayaz A and Aghakhani A. Animal Bites in Tehran, Iran. Archives of

Iranian Medicine 11(2):200-202(2008)

• Ramezani A, Mohraz M…….Dyslipidemia and metabolic abnormalities in

HIV-infected patients. Iranian Journal of Infectious Disease and Tropical

Medicine. 12(39):5-9(2008).

• Hamkar R, Yahyapour Y,…Ramezani A….Prevalence of viral agents among

children with acute gastroenteritis in Mazandaran province, 2004-2005.

17

Iranian Journal of Infectious Disease and Tropical Medicine. 12(39):5-

9(2008).

• Sofian M., Aghakhani A., Velayati A.A., Banifazl M, Eslamifar A. and

Ramezani A. Risk factors for human brucellosis in Iran: a case control study.

International Journal of Infectious Diseases .12(2):157-61(2008)

• Ramezani A. Gachkar L, Eslamifar A,….Detection of hepatitis G virus

envelope protein E2 antibody in blood donors. International Journal of

Infectious Diseases .12(1):57-61(2008)

• Ramezani A, …, Banifazl M, Eslamifar A,….and Aghakhani A. Metabolic

abnormalities in HIV-positive patients receiving highly active antiretroviral

therapy. Iranian Journal of Pathology 2 (4):154-58 (2007).

• Jam S, Sabzevari D, Aghakhani A, Eslamifar A, Banifazl M and Ramezani A.

Antimicrobial susceptibility pattern of clinical isolates of Pseudomonas

aeruginosa in a pediatric hospital. Iranian Journal of Pathology 2(4):144-

48(2007)

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

Virus Exposure in Dialysis Patients. International Urology and Nephrology

.39(4): 1257-1263 (2007).

• Soofian M,…. Eslamifar A, Aghakhani A, Ramezani A. Eosinophilic

gastroenteritis: A case report. Iranian Journal of Infectious Disease and

Tropical Medicine .12(38):63-6(2007).

• Ramezani A, Eslamifar A, Aghakhani A,…..Blood mercury levels in infants

receiving vaccines containing Thimerosal. Iranian Journal of Infectious

Disease and Tropical Medicine. 12(38):17-20(2007).

18

• Eslamifar A, Hamkar R, Ramezani A, ……and Aghakhani A. Hepatitis G

virus (HGV) Exposure in Dialysis Staff. Therapeutic Apheresis and Dialysis.

11(5):370-374(2007).

• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus

exposure in blood donors. Iranian Journal of Infectious Disease and Tropical

Medicine. 12(37) (2007) .

• Eslamifar A, Tirgari F, Hamkar R, Ramezani A …… Deljoodokht Z and

Aghakhani A. Role of the Human Papillomavirus infection in Esophageal

Squamous Cell Carcinoma. Iranian Journal of Pathology. 2(1):11-16(2007).

• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in

chronic B hepatitis. Iranian Journal of Infectious Diseases and Tropical

Medicine. 12(37): 1-6(2007).

• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A,..... Frequency of

Human Papillomavirus Infection in Iranian Esophageal Squamous Cell

Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-

62(2007)

• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G Virus

Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of Infectious

Diseases and Tropical Medicine. 11(35): 73-79 (2007).

• Ramezani A, Gachkar L, Eslamifar A…Prevalence of Hepatitis G virus

exposure in blood donors. Infectious diseases and tropical medicine journal.

37(12), (2007).

• Ramezani A, Mohraz M,…..Anemia and associated factors in individuals

with Human immunodeficiency virus infection. Infectious diseases and

tropical medicine journal. 36(12):29-32(2007).

19

• Ramezani A, Aghakhani A……Eslamifar A…. Natural YMDD mutants in

chronic B hepatitis. Infectious diseases and tropical medicine journal. 12(37):

1-6(2007).

• Eslamifar Ali, Aghakhani A, Hamkar R, Ramezani A, et al..... Frequency of

Human Papillomavirus Infection in Iranian Esophageal Squamous Cell

Carcinoma patients. Scandinavian Journal of Infectious Disease .39(1):58-

62(2007)

• Eslamifar A., Aghakhani A. Ramezani A.,... Detection of Hepatitis G Virus

Envelope Protein E2 Antibody in Dialysis Staff .Iranian Journal of Infectious

Diseases and Tropical Medicine, 11( 35): 73-79 (2007)

• Ramezani A, Mohraz M, Gachkar L. (2006) Epidemiologic situation of

HIV/AIDS in Iranian patients referred to ... Archives of Iranian Medicine. 9(

4):315-318.

• Ramezani A, Mohraz M, Gachkar L. (2006) Frequency of positive purified

protein derivative in Human Immunodeficiency Virus infected individuals.

Archives of Iranian Medicine, 9 (3): 218-221.

• Ramezani A, Eslami far A, Amirkhani A, Hazrati M, Taeb J and Deljoo Z.

Factors influencing to hepatitis B vaccination response in hemodialysis

patients of Tehran (Iran) Iranian Journal of Infectious Diseases and Tropical

Medicine, Vol. 10, No. 32. (2006).

• Eslamifar A., Aghakhani A., Hamkar R., Ramezani A., Tirgari F., Frootan H.,

Mirmomen Sh., Gheini MH. , Deljoodookht Z., Taeb J. (2006) Detection of

High Risk Human Papillomaviruses in Esophageal Squamous Cell Carcinoma

by PCR and DNA Sequencing. Iranian Journal of Infectious Diseases and

Tropical Medicine, Vol. 11, No. 33.

20

• Roshan M.R, Mohraz M, Ramezani A, Haji Ahmadi M and Velayati A.A.

(2006) Efficacy of gentamycine plus doxycycline versus Streptomycin plus

doxycyline. Clinical Infectious Disease. 15; 42(8).

• Ramezani A, …, Asgharzadeh A, Parastan R, Aliahmadi A Eslamifar A,

Velayati A.A. (2005) Molecular epidemiology of clinical strains of enteococci

Faecium in Tehran hospitals. Iranian Journal of Infectious Diseases and


• Ramezani A, Eslamifar A, Nazgooei F. (2004) Epidemiological Study of

animal bites in persons referred to institute Pasteur of Iran (Tehran province)

2003. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,

No. 27.

• Ahmadi F, Maziyar S, Ramezani A, Lesan. (2004) Evaluation of hepatitis B

immunity and influencing factors on hemodialysis patients response to HB

vaccine. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,

No. 27

• Ramezani A, Eslamifar A, Hazrati M. (2004) Relation of vaccine includes

thiomersal with neurodevelopment disorders in neonates and embryonic

periods. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,

No. 26.

• Etemadi G, Ramezani A. (2004) Report of several cases of streptococcus

pneumonia in rural family (Qom). Iranian Journal of Infectious Diseases and


• Ramezani A, Eslami far A, Nazgooei F, Eslami L. (2004) Epidemiology of

animal rabies in Tehran province (2002-2003). Iranian Journal of Infectious

Diseases and Tropical Medicine, Vol. 9, No. 25.

21

• Ramezani A, Mohraz M, Nazgooei F. (2004) Study frequency of M. Hominis

and ureaplasma urealyticum in patients referred to private office. Iranian

Journal of Infectious Diseases and Tropical Medicine, Vol. 9, No. 24.

• Vahdani P, Darreh F, …, Ramezani A. (2004) First case of infantile botulism

in Iran. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 9,

No. 24.

• Roshan M.R, Ramezani A. (2002) Result of long term follow up in chronic

carrier of Hepatitis B in Babol (2000-2001). Iranian Journal of Infectious

Diseases and Tropical Medicine, Vol. 16, No. 7.

• Ramezani A. Effectiveness of Ethanol concentration on resistant M.

Tuberculosis in vitro. (2002) Iranian Journal of Infectious Diseases and


• Ramezani A , Mohraz M, Asadi S, Nazgooei F, Eslami far A. (2002) Survey

situation of nosocomial infection due to enterococci in Tehran Hospitals.

Infectious Diseases and Tropical Medicine Journal, Vol. 7, No. 19.

• Ramezani A, Mohraz M, Asadi S ,Nazgooei F, Eslamifar A. (2002) Survey

situation of nosocomial infection due to enterococci in Tehran hospitals.

Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 7, No. 19.

• Babaei A, Ramezani A. (2002) Study of garlic effectiveness on resistant M.

Tb. Iranian Journal of Infectious Diseases and Tropical Medicine, Vol. 7, No.

19.

• Feizabadi MM, Ali Ahmadi A, Parastan R, Ramezani A, Asadi S. (2002)

Biotype variation in E. Facium strains isolated from admitted patients in

Tehran Hospitals. Iranian Journal of Infectious Diseases and Tropical

Medicine, Vol. 7, No. 18.

22

• Feizabadi MM, Aliahmadi A, Mobasheri F, … , Ramezani A. (2002)

Identification antimicrobial resistancy pattern of Enterococci strains isolated

from patients admitted to Tehran University Hospitals. Infectious Diseases and

Tropical Medicine Journal, Vol. 7, No. 16.

Books:

• New edition of "Guide to antimicrobial therapy and vaccination" .Chief

Editor: Iranian Society for Infectious Diseases and Tropical Medicine

publication (2013)

• New edition of "Guide to antimicrobial therapy and vaccination". Pousheh

Publication, Tehran, Iran (2012)


Editor: Iranian society for infectious diseases and tropical medicine

publication (2010).

• Tourism Medical Information and Guideline. Pejvak Ghalam and BUMS

publication. Tehran (2010)

• Risk factors for human brucellosis in Iran (In English & German). VDM

Verlag publication (2009).


Editor: Iranian society for infectious diseases and tropical medicine

publication (2009).

• International Travel Medicine. Iran Helal Institute of Applied Science and

Technology Publication, Tehran (2009).

• New edition of "Guide to antimicrobial therapy" .Chief Editor: Iranian Society

for Infectious Diseases and Tropical Medicine (2008).

23





• Guide to Antimicrobial Therapy. Chief Editor: Iranian Society for Infectious

Diseases and Tropical Medicine (2005).

• Abstract Book of National Iranian Congress of Brucellosis Chief Editor

Shaheed Beheshti University. ISBN 964-7271-83-2, 2005

• Antibiotic Guidelines. Chief Editor: Iranian Society for Infectious Diseases

and Tropical Medicine (2004).

• Nelson Textbook of Pediatrics, Chapter of Neonatology Translation English to

Persian, Teimoorzadeh Publication ISBN 964-456-914-8, 2004

• Nelson Textbook of Pediatrics, Chapter of Immunology, Allergy, and

Rheumatology Translation English to Persian, Teimoorzadeh Publication

ISBN 964-456-915-6 ,2004

• Nelson Textbook of Pediatrics, Chapter of Infectious Diseases Translation

English to Persian, Teimoorzadeh Publication ISBN 964-456-898-2 ,2004

• Textbook of Infectious Diseases. Chief Editor: Poursina Publication ISBN

964-5670-64-0, 2002

• Textbook of Tuberculosis. Chief : Poursina Publication ISBN 964-5670-66-7,

2002

• Nelson Textbook of Pediatrics, Chapter of Infectious Diseases Translation

English to Persian, Teimoorzadeh Publication 2000

• Nelson Textbook of Pediatrics, Chapter of Neonatology Translation English to

Persian, Teimoorzadeh Publication 2000

24

• Nelson Textbook of Pediatrics, Chapter of Respiratory Diseases Translation

English to Persian, Teimoorzadeh Publication 2000

• Nelson Textbook of Pediatrics, Chapter of Immunology Translation English to

Persian, Teimoorzadeh Publication, ISBN 964-456-457-X, 2000

• Nelson Textbook of Pediatrics, Chapter of Allergy Translation English to

Persian, Teimoorzadeh Publication, ISBN 964-456-457-X ,2000

• Epidemiology and Health. Editor: Arzandeh Publication, ISBN 964-92092-5-

5, 2000

Presentations

1. Sofian M, Aghakhani A, Amir-Moezzi R , Zarinfar N, Banifazl M, Eslamifar A

and Ramezani A. Prevalence of HIV, HCV and HBV Infections and Associated

Risk Factors among Injecting Drug Users in Arak City. 21st Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2013)

2. Sofian M, Sheikholeslami M, Sarmadian H, Mahdaviani F, Aghakhani A,

Eslamifar A, Deiri GH, Ramezani A. Seroprevalence of Brucellosis Antibodies

in Blood Donors in Central Province of Iran. 21st Iranian congress on infectious

diseases and tropical medicine, Tehran, Iran (2013)

3. Sofian M, Safaeipour L, Aghakhani A, Banifazl M, Eslamifar A, Farazi A, Didgar

F, Ramezani A. Importance of Family Members Screening of Cases with Acute

Brucellosis. 21st Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2013)

4. Ramezani A, Mohraz M, Eslamifar A, Banifazl M, ….. and Aghakhani A.

Hepatitis E virus co-infection in HIV infected patients. 21st Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2013)

25

5. Aghakhani A, Aghasadeghi MR, Banifazl M, Eslamifar A, …..and Ramezani A.

Occult Hepatitis B Virus Infection in Hemodialysis Patients. 21st Iranian congress

on infectious diseases and tropical medicine, Tehran, Iran (2013)

6. Ramezani A, Eslamifar A, Banifazl M, Ahmadi F, Aghakhani A. Follow up of

Hemodialysis Patients with Occult Hepatitis B Virus Infection. 21st Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2013)

7. Ramezani A, Aghasadeghi M, Bahramali G, Aghakhani A, Banifazl M, …….

Eslamifar A, Siadat S, Mohraz M. Frequency of hepatitis D virus infection in

HIV-positive and haemodialysis patients in Iran. 22nd

European Congress of

Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)

8. Soufian S, Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, Mohraz M.

Reduction in interleukin-2 serum levels but lack of evidence of the Th1 to Th2

cytokine shift during the course of HIV infection. 22nd

European Congress of

Clinical Microbiology and Infectious Diseases (ECCMID), London, UK (2012)

9. Sofian M, Banifazl M, Aghakhani A, ….. Ramezani A. Evaluation of interleukin-

10 gene promoter polymorphisms and hepatitis B virus infection outcome. 22nd

European Congress of Clinical Microbiology and Infectious Diseases (ECCMID),

London, UK (2012)

10. Ramezani A, Sofian M, Aghakhani A, Farazi A, Banifazl M,. Eslamifar A,

Velayati A. Serum profile of T helper 1 and T helper 2 cytokines in HCV-infected

patients. 22nd

European Congress of Clinical Microbiology and Infectious

Diseases (ECCMID), London, UK (2012)

11. Sofian M , Ramezani A, Aghakhani A, Banifazl M, Eslamifar A, …..

Comparison of Brucella Induced epididymo-orchitis with Nonspecific Epididymo-

26

orchitis in an Endemic Area for Brucellosis. 20th

Iranian congress on infectious

diseases and tropical medicine, Tehran, Iran (2011)

12. Ramezani A, Sofian M, Aghakhani A ,…. Banifazl M, Eslamifar A, ….. Serum

Profile of T helper 1 and T helper 2 Cytokines in HCV Infected Patients. 20th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran (2011)

13. Ramezani A, Aghasadeghi MR, Bahramali G, Aghakhani A, Banifazl M,

…..Eslamifar A, ….. Frequency of hepatitis D virus infection in HIV positive and

hemodialysis patients in Iran. 20th

Iranian congress on infectious diseases and

tropical medicine, Tehran, Iran (2011)

14. Ramezani A, Aghakhani A, Banifazl M, Forough M, Eslamifar A and Mohraz M.

Seroprevalence of Human T-Cell Leukemia Virus Type 1 (HTLV-1) and HTLV-2

Infection in HIV Infected Patients. 20th

Iranian congress on infectious diseases

and tropical medicine, Tehran, Iran (2011)

15. Ramezani A, Sofian M, Banifazl M, Aghakhani A,….. Eslamifar A, …..

Evaluation of Interleukin-10 Gene Promoter Polymorphisms and Hepatitis B

Virus Infection Outcome. 20th

Iranian congress on infectious diseases and tropical

medicine, Tehran, Iran (2011)

16. Eslamifar A, Ramezani A, Mohraz M, Banifazl M, Forough M and Aghakhani A.

Tetanus and diphtheria seroprevalence in HIV infected patients. 20th

Iranian


17. Panel about Brucellosis. 10th

midyear conference of infectious diseases. Babolsar,

Iran (2011)

18. Ramezani A, ….., Aghakhani A, Soufian S, Eslamifar A and Banifazl M.

Mutations in the S gene region of hepatitis B virus in High Risk Patients with

Occult HBV Infection. 20th ECCMID, Vienna, Austria (2010)

27

19. Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A and Ramezani A.

Distribution of pertussis antibodies among Iranian children of different age

groups. 20th ECCMID, Vienna, Austria (2010)

20. Ramezani A, Hamkar R, Aghakhani A, Banifazl M, ….. Prevalence of Secondary

Resistant Mutations to Antiretroviral Drugs in Iranian HIV Infected Patients. 20th

ECCMID, Vienna, Austria (2010)

21. Ramezani A, Aghakhani A, Sofian M, …., Khadem-Sadegh A and Banifazl M.

Seroepidemiology of Hepatitis A Virus in Iranian Children. 20th ECCMID,

Vienna, Austria (2010)

22. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of isolated

antibody to hepatitis B core antigen in HIV- HCV coinfected individuals. 14th

ICID - Miami, Florida, USA (2010)

23. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Association of

polymorphism of HLA-DRB1 13 and HLA-A 33 alleles with outcome of hepatitis

B virus infection. 14th ICID - Miami, Florida, USA (2010)

24. Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M and Ramezani A.

The Role of Human Papillomavirus Infection in Prostate Carcinoma. 14th ICID -

Miami, Florida, USA (2010)

25. Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. No evidence of

occult hepatitis B virus infection among anti-HBc-positive blood donors in an area

of low endemicity for HBV. 14th ICID - Miami, Florida, USA (2010)

26. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Frequency of occult

hepatitis B virus infection in HIV infected patients. 14th ICID - Miami, Florida,

USA (2010)

28

27. Ramezani A, …,Aghakhani A, Eslamifar A, …. Banifazl M. The epidemiology

of tuberculosis in Arak city, Central province of Iran from 1997-2007. 14th ICID -


28. Ramezani A, Aghakhani A, Eslamifar A, …. Banifazl M. Anti-HBs titers in

vaccinated children and adolescents: Implication for booster administration. 14th

ICID - Miami, Florida, USA (2010)

29. Ramezani A, Banifazl M,…….. Eslamifar A,… Aghakhani A. Prevalence of

Occult Hepatitis B Infection in Iranian Injection Drug Users. 14th ICID - Miami,

Florida, USA (2010)

30. Sofian M,….. Aghakhani A, Banifazl M, Ramezani A. Predictive value and cut

off point of PPD in probable patients with pulmonary tuberculosis. 14th ICID -


31. Sofian M,….. Ramezani A,…. Aghakhani A, Banifazl M. Prevalence of isolated

hepatitis B core antibody among injection drug users in central province of Iran.

14th ICID - Miami, Florida, USA (2010)

32. Eslamifar A, Ramezani A, Banifazl M, Bidari F, Moradi A and Aghakhani A.

Association of Human Papillomavirus and Breast Carcinoma.19th Iranian


33. Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Banifazl M. Occult and

chronic hepatitis B, hepatitis C, and HIV infections and co-infections among

injection drug users. 19th Iranian congress on infectious diseases and tropical

medicine, Tehran, Iran (2010)

34. Panel about Hepatitis. 9th

midyear conference of infectious diseases. Kish, Iran

(2010)

29

35. Ramezani A, Mohraz M, Aghakhani A, ….. Eslamifar A, …. Genotype

characterization of hepatitis G virus isolates from Iranian patients infected with

human immunodeficiency virus. 19th ECCMID, Helsinki, Finland(2009)

36. Ramezani A, Aghakhani A, Mohraz M, Eslamifar A, Khadem-Sadegh A,

Banifazl M. Occult hepatitis B virus infection in “anti-HBc alone” haemodialysis

patients. 19th ECCMID, Helsinki, Finland(2009)

37. Sofian M, Ramezani A, ….. Aghakhani A, Eshrati B, Eslamifar A, Banifazl M.

Predictive value of purified protein derivative in pulmonary tuberculosis in a high

BCG-vaccinated population. 19th ECCMID, Helsinki, Finland(2009)

38. Aghakhani A, Hamkar R, …Eslamifar A,….Ramezani A. Identification of

hepatitis B virus genotype in patients with hepatocellular carcinoma in Iran.19th

ECCMID, Helsinki, Finland (2009)

39. Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.Significance

of Hepatitis B Core Antibody as the Only Marker of Hepatitis B Virus Infection.

The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009)

40. Aghakhani A, Mohraz M, Banifazl M, Eslamifar A, Khadem-Sadegh A and

Ramezani A. Frequency of isolated antibody to hepatitis B core antigen in HIV-

HCV coinfected individuals. The 3rd Annual Iranian Congress on HIV/AIDS.

Tehran, Iran (2009)

41. Ramezani A, Mohraz M, Aghakhani A, Banifazl M, Eslamifar A,……Hamkar R.

Frequency of Occult Hepatitis B Virus Infection and its Surface Mutants in HIV

Positive Patients. The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran

(2009)

30

42. Hamkar R, Ramezani A, Aghakhani A, Banifazl M, …Mohraz M. Frequency of

drug resistance mutations in HIV-positive patients receiving antiretroviral therapy.

The 3rd Annual Iranian Congress on HIV/AIDS. Tehran, Iran (2009).

43. Ramezani A, Sofian M, Aghakhani A, Eslamifar A, Izadi N, Banifazl M. Occult

hepatitis B virus infection in blood donors with isolated anti-HBc. 18th

Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2009).

44. Aghakhani A, Hamkar R, Parvin M, Eslamifar A, Banifazl M, Ramezani A.

Association of Human Papillomavirus with Prostate Cancer. 18th

Iranian congress

on infectious diseases and tropical medicine, Tehran, Iran (2009).

45. Eslamifar A, Aghakhani A, Banifazl M, Khadem-Sadegh A, Ramezani A.

Seroepidemiology of pertussis antibodies among children of different age groups.

18th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran

(2009).

46. Ramezani A, …., Aghakhani A, Eslamifar A, Soufian S, Banifazl M. Hepatitis B

virus Surface Gene Mutations in High Risk Patients with Occult HBV Infection.

18th

Iranian congress on infectious diseases and tropical medicine, Tehran, Iran

(2009).

47. Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.

Age specific seroprevalence of hepatitis A antibody: Implications for health

policy. 18th

Iranian congress on infectious diseases and tropical medicine, Tehran,

Iran (2009).

48. Ramezani A, Aghakhani A,…… Eslamifar A, Khadem-Sadegh A, Banifazl M.

Seroprevalence of hepatitis B surface antibody in children subjected to the

Expanded Programme on Immunization (EPI). 18th

Iranian congress on infectious

diseases and tropical medicine, Tehran, Iran (2009).

31

49. Panel about chronic hepatitis B. 8th

midyear conference of infectious diseases.

Babolsar, Iran (2009).

50. Ramezani A, …, Eslamifar A, …, Aghakhani A, Edalat R, Hekmat S. Hepatitis G

virus infection in patients infected with the human immunodeficiency virus. 13th

ICID - Kuala Lumpur, Malaysia (2008)

51. Ramezani A,…… Eslamifar A,…..Taeb J, Aghakhani A….. Association between

HLA-A, B, DRB1 alleles and susceptibility or resistance to chronic hepatitis B.

13th ICID - Kuala Lumpur, Malaysia (2008)

52. Ramezani A,…. Aghakhani A, Eslamifar A…. Prevalence of Metabolic

abnormalities in HIV-Infected Patients Receiving Highly Active Antiretroviral

Therapy and antiretroviral-naive patients. 13th ICID - Kuala Lumpur, Malaysia

(2008)

53. Ramezani A, Eslamifar A, ….. and Aghakhani A. Long term Immune response to

hepatitis B vaccine in hemodialysis patients. 13th ICID - Kuala Lumpur, Malaysia

(2008)

54. Ramezani A, … Eslamifar A,……and Aghakhani A. Comparison of IFN-gamma

assay and Tuberculin Skin Test for detecting latent tuberculosis infection in BCG-

vaccinated population. 13th ICID - Kuala Lumpur, Malaysia (2008)

55. Eslamifar A, Aghakhani A, Ramezani A,……. The role of fungi in the etiology

of chronic rhinosinusitis. 12th International Congress of Mycology. Istanbul,

Turkey(2008)

56. Soofian M, Ramezani A, ...., Aghakhani A, Eslamifar A. Risk factors for human

brucellosis in Iran: a case control study. ECCMID-ICC, Munich, Germany (2007).

57. Aghakhani A, Hamkar R,…….Eslamifar A,…..Ramezani A. Genotype

Characterization of Hepatitis B Virus Isolates from Iranian Patients with

32

Hepatocellular Carcinoma . 10th annual congress of pathology and 4th annual

congress of Iranian cancer association, Tehran, Iran (2008).

58. Eslamifar A,…. Ramezani A,….and Aghakhani A. Frequency of Fungi and

Eosinophilic Granulocytes in Chronic Rhinosinusitis . 10th annual congress of

pathology and 4th annual congress of Iranian cancer association, Tehran, Iran

(2008).

59. Ramezani A, Mohraz M, Banifazl M, Eslamifar A and Aghakhani A.

Significance of Hepatitis B Core Antibody as the Only Marker of Hepatitis B

Virus Infection. 17th Iranian congress on infectious diseases and tropical

medicine, Tehran, Iran (2008).

60. Ramezani A,….. Aghakhani A,… Eslamifar A and Velayati AA. Genotype

characterization of hepatitis G virus isolates from Iranian patients infected with

human immunodeficiency virus (HIV). 17th Iranian congress on infectious


61. Ramezani A, …, Aghakhani A, Banifazl M, Eslamifar A, Khadem-Sadegh A,

Velayati AA. Frequency of isolated antibody to hepatitis B core antigen in HIV-

HCV coinfected individuals. 17th Iranian congress on infectious diseases and

tropical medicine, Tehran, Iran (2008).

62. Ramezani A, Aghakhani A,…. Eslamifar A,… Association of polymorphism of

HLA-DRB1*13 and HLA-A *33 alleles with outcome of hepatitis B virus

infection. 17th Iranian congress on infectious diseases and tropical medicine,

Tehran, Iran (2008).

63. Ramezani A, Mohraz M, Aghakhani A, Banifazl M, …. Frequency of occult

hepatitis B virus infection in HIV infected patients. 17th Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2008).

33

64. Ramezani A, Aghakhani A, Eslamifar A, Khadem-Sadegh A, Banifazl M. Occult

hepatitis B virus infection in "anti-HBc alone" hemodialysis patients. 17th Iranian

congress on infectious diseases and tropical medicine, Tehran, Iran (2008).

65. Panel about Treatment of HBeAg negative chronic Hepatitis B. 7th midyear

conference of infectious diseases. Isfahan, Iran (2008).

66. Ramezani A, Mohraz M, Banifazl M, Aghakhani A…. Frequency of proteinuria

among HIV-infected patients .ECCMID-ICC, Munich, Germany (2007).

67. Eslamifar A., Aghakhani A, Ramezani A,…… Prevalence of hepatitis G

exposure in patients on chronic dialysis. 21st European Congress of Pathology,

Istanbul, Turkey (2007).

68. Kariminia A, sharifnia Z, Aghakhani A, .. Eslamifar A,… and Ramezani A.

Performance of QuantiFERON TB-G Test for detecting latent tuberculosis

infection in BCG-vaccinated population. 16th Iranian congress on infectious


69. Ramezani A, Eslamifar. A ...and Aghakhani A. Persistence of Hepatitis B

Vaccine Immunity in Hemodialysis Patients.16th Iranian congress on infectious

diseases and tropical medicine, Tehran,Iran (2007).

70. Ramezani A,... Aghakhani A, Eslamifar A... Frequency of hepatitis B and

hepatitis C virus infections in HIV infected subjects.16th Iranian congress on

infectious diseases and tropical medicine, Tehran, Iran (2007).

71. Ramezani A, Mohraz M, Aghakhani A, Eslamifar A,... Impact of antiretroviral

treatment on lipid profile in HIV infected patients. 16th Iranian congress on

infectious diseases and tropical medicine, Tehran,Iran (2007).

34

72. Ramezani A, Mohraz M ... Aghakhani A, Eslamifar A... Anemia in HIV-infected

patients receiving highly active antiretroviral therapy. 16th Iranian congress on

infectious diseases and tropical medicine, Tehran,Iran (2007).

73. Ramezani A. Hasanjani Roshan MR... Eslamifar A, Taeb J, Aghakhani A...

Influence of HLA class І and II alleles on the outcome of hepatitis B virus

infection. 16th Iranian congress on infectious diseases and tropical medicine,


74. Ramezani A ... Eslamifar A and Aghakhani A. Detection of YMDD mutation in

Iranian chronic hepatitis B patients before lamivudine treatment. 9th annual

congress of pathology and 3rd annual congress of Iranian cancer association,


75. Mohraz M, Ramezani A, Banifazl M...and Aghakhani A. Frequency and

Associated Factors of Proteinuria in HIV-Positive Patients .The first annual AIDS

research congress of Iran. Tehran, Iran (2007).

76. Panel about Hepatitis in 6th midyear conference of infectious diseases. Babolsar

16-19 Oct (2007).

77. Esalamifar A, Aghakhani A, Hamkar R, Ramezani A....Frequency of Human

Papillomavirus Infection in Esophageal Squamous Cell Carcinoma of Iranian

patients. 12th International Congress on Infectious Diseases, Lisbon, Portugal

(2006)

78. Eslamifar A, Ramezani A....and Aghakhani A. Hepatitis G virus exposure in

dialysis patients. 8th annual congress of pathology and 2nd congress of oncology,

Tehran, Iran (2006)

35

79. Eslamifar A , Hamkar R, Ramezani A....and Aghakhani A. Role of human

papillomavirus infection in esophageal carcinoma.8th annual congress of

pathology and 2nd congress of oncology, Tehran, Iran (2006)

80. Eslamifar A, Aghakhani A, Ramezani A, et al. Epidemiology of Animal Bites in

Tehran.15th Iranian congress on infectious diseases and tropical medicine,

Tehran,Iran (2006)

81. Eslamifar A, Hamkar R, Ramezani A……and Aghakhani A. Hepatitis G virus

(HGV) Exposure in Dialysis Staff. 15th Iranian congress on infectious diseases

and tropical medicine, Tehran,Iran (2006)

82. Ramezani A , ………, Eslamifar A and Aghakhani A .YMDD mutants in

patients with chronic hepatitis B before treatment are not selected by

lamivudine.15th Iranian congress on infectious diseases and tropical medicine,

Tehran,Iran (2006)

83. Eslamifar A, Hamkar R, Ramezani A ……and Aghakhani A. Exposure to

Hepatitis GB Virus in Patients on Maintenance Hemodialysis. 15th Iranian


84. Ramezani A, Eslamifar A….Factors influencing to hepatitis B virus vaccination

in hemodialysis patients. XLIII ERA-EDTA Congress(Glasgow, United Kingdom,

July 15-18,( 2006)

85. Ramezani A, Eslamifar A,….Frequency of Hepatitis G infection among Iranian

blood donors.12th international congress on infectious diseases, Lisbon

,Portugal(2006)

86. Ramezani A, …Vancomycin resistant enterococci fecalis in clinical

specimen12th international congress on infectious diseases, Lisbon,

Portugal(2006)

36

87. Ramezani A, Eslamifar A,…Assessment of blood mercury levels in infants

exposed to vaccines containing thiomersal. 2nd international congress on

infectious and tropical diseases in Oman( 2006)

88. Ramezani A., Eslamifar A…Efficacy of hepatitis B vaccination schedule and

comparing to complete regimen hemodialysis patients of Iran.12th international

congress on infectious diseases, Lisbon , Portugal(2006)

89. Panel about Hepatitis in 5th midyear conference of infectious diseases Babolsar 1-

2 Nov (2006).

90. Panel about antimicrobial resistance in 5th midyear conference of infectious

diseases Babolsar 1-2 Nov (2006)

91. Ramezani A, Mohraz M, Banifazl M. Epidemiological situation of HIV/AIDS

patients in Iran. 10th European AIDS Conference/EACS. Nov. 17-20. (2005)

92. Rahmani H, Gachkar L, Ramezani A. HCV and HBV co-infection in HIV1

infected patients in Tehran (Iran).10th European AIDS Conference/EACS, Nov.

17-20. (2005)

93. Ramezani A, Mohraz M, Banifazl M. Frequency of vancomycin resistant

Enterococci faecium in hospitals of Tehran. 4th International Meeting on

Antimicrobial Chemotherapy in Clinical Practices Santa Margrita Portophino,

Nov. 10-12. (2005)

94. Ramezani A, Mohraz M, Banifazl M. Molecular epidemiology of vancomycin

resistant Enterococci fecium in Iran during 2000-2003. 4th International Meeting

on Antimicrobial Chemotherapy in Clinical Practices Santa Margrita Portophino,

Nov. 10-12, (2005)

37

95. Gachkar L, Ramezani A, Eslamifar A, Hamkar R, Khoshbaten M, Hazrati M.

Frequency of Hepatitis G infection among Iranian blood donors. 14th Congress of

Infectious Disease, Dec. 17-21. (2005)

96. Ramezani Amitis, Eslamifar Ali, …. Factors influencing to hepatitis B

vaccination response in hemodialysis patients of Tehran (Iran). 14th Congress of

Infectious Disease, Dec. 17-21. (2005)

97. Roshan M.R, Mohraz M, Ramezani A, Haji Ahmadi M and Velayati

A.A Efficacy of gentamycine plus doxycycline versus Streptomycin plus

doxycyline. International research conference for disclosure brucellosis small

rominants and humans. Macedonia, Nov. 28-30. (2005)

98. Lecture about nosocomial infection in Midyear Conference of Infectious Diseases

Babolsar, Sep. 27-29, (2005)

99. Panel about AIDS in 14th Congress of Infectious Diseases. Dec. 17-21, (2005)

100. Lecture about vaccination in Midyear Conference of Infectious Diseases

(2004)

101. Speech about vaccination and bites for General physician in Shaheed Beheshti

University (2004)

102. Panel about AIDS, Hepatitis, IDU, in 13th Congress of Infectious Diseases

(2004)

103. Rates of scar failure in children vaccinated with BCG. 13th Congress of

Infectious Diseases (2004)

104. Eslamifar A, Ramezani A, Nazgooie F, Mafakheri M, Hosseini Z Naseri M.R.

Situation of MR vaccination on mass campaign project in persons referred to

Institute Pasteur of Iran. 12th Congress of Infectious Diseases.(2003)

38

105. Babaiei M.R, Ramezani A. Effectiveness of Ethanol concentration as an

effective material for shortness Growth of M. Tuberculosis in culture. 11th

Congress of Infectious Diseases.(2002)

106. Babaiei M.R, Ramezani A. Effectiveness of Ethanol concentration on

resistant M. Tuberculosis in vitro. 11th Congress of Infectious Diseases.(2002)

107. Speech about urinary tract infection in Midyear Conferences of Infectious

Diseases (2002)

108. Babaei A, Ramezani A, Banifazl M. Study of garlic effectiveness on resistant

M. Tb. 11th Congress of Infectious Diseases.(2002)

109. Lecture about pneumonia for general physician in Babol University (2001)

110. Ramezani A, Karami A, Banifazl M. Complications of Anti tuberculosis

drugs in 1000 tuberculosis patients in Imam Khomeini Hospital (Tehran) (1991-

1997). 9th Iranian Congress on Infectious Disease, Jan. 14-18.(2001)

111. Ramezani A, Karami A, Banifazl M, Survey side effects of antituberculosis

drugs in 1000 out patient and inpatient tuberculosis patients in Imam Khomeini

Hospital of Tehran from 1992-1998. 9th Iranian Congress on Infectious Disease,

Jan. 14-18.(2001)

112. Ramezani A, Babaiei M.R, …. Epidemiological characteristics (primary

resistancy, failure, cure, conversion rate …) in tuberculosis patients referred to

Pasteur Institute of Iran. 9th Congress of Infectious Diseases.(2000)

113. Hadizadeh A.R, Karimi A, Babaiei M.R, Ramezani A. Evaluation relation of

age & clinical manifestation in patients suspicious to tuberculosis in Pasteur

Institute of Iran (1999-2000). 9th Congress of Infectious Disease.(2000)

39

114. Ahangari F, Ramezani A, Prevalence of sensorineural hearing loss due to

bacterial meningitis and factors associated in Tehran University (1997-1998). 9th

Congress of Infectious Diseases.(2000)

115. Etemadi G, Ramezani A, Ghazisaiedi K. Antimicrobial resistancy of bacteria

isolated from intestinal infection in patients referred to university of Health

between (1978-1991). 8th Congress of Infectious Diseases.(1999)

116. Bacteriology testing in tuberculosis patients features, risk factors and

prognosis. 8th Congress of Infectious Diseases (1999)

117. Ramezani A, Saghari H, Ghazisaedi K .Retrospective survey on the enteric

bacterial pathogens in patients referred to university of Health between1978-1991.

8th Congresses of Infectious Diseases.(1999)

118. Drug resistant tuberculosis and clinical outcome in patients in Tehran. 8th

Congress of Infectious Diseases (1999)

119. Ramezani A, Banifazl M. Survey 88 cases of infected abortion. 8th Congress

of Infectious Diseases.(1999)

Teaching course:

Infectious disease courses for M.Sc. and PhD students

Awards:

• Winner of Tehran University Book Award (1380)

• Best assistant professor of Pasteur institute of Iran (1389)

Gene Patents:

• 42 HIV gene in Gen Bank NCBI

40

• 21 HPV gene in Prostate cancer in Gen Bank NCBI

• 8 HBV gene in occult HBV infections in Gen Bank NCBI

• 40 HBV gene in hepatocellular carcinoma in Gen Bank NCBI

• 10 HGV gene in HIV infected patients in Gen Bank NCBI

• 34 HPV gene in esophageal cancer in Gen Bank NCBI

curriculum vitaejommid.pasteur.ac.ir/files/site1/pages/amitis_ramezani.pdf1 curriculum vitae name:...

Documents